{"success":true,"data":{"pressRelease":{"id":"155657","rtpr_id":"nGNXb8mtBm-20260929","ticker":"HIMS","exchange":"NYSE","all_tickers":["HIMS"],"title":"HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law ","author":"Globe Newswire","published_at":"2026-09-29T14:15:54.105Z","article_body":"LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) --  Schall, Brown & Schwartz LLP\n(https://www.globenewswire.com/Tracker?data=Jly_J51_tZOz2yuADjKji9KdPh-LH21Nay23erbV4Z7NlTxq3ozXiDouiwWyPZx99UC2Xs_vOtAQBszxLSP9uXJvWb86MuOaM5ov0Gl4DHyo5bAEJuVWTsphsfD9XXFr)\n(“SBS”), a national shareholder rights litigation firm, reminds investors\nof a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers”\nor “the Company”) (NYSE: HIMS\n(https://www.globenewswire.com/Tracker?data=X4FpbU2RzQy3OPeSX79TTdpwSGwqe3eLWoOlYw8AXTABu1cvkZXS3isBqubZKH0JnKAyboReRW0O0Nl17EE16h3Smm_Zb4Rb57IfrkCvLFM=))\nfor violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934\nand Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange\nCommission.\n\nShareholders who purchased shares of HIMS during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointments.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCLASS PERIOD: August 4, 2025 to July 29, 2026\n\nDEADLINE: November 2, 2026\n\nIf you are a shareholder who suffered a loss, click here to participate\n(https://www.globenewswire.com/Tracker?data=e85GHZtY26Km3i9JqGaK9yM_qzf1Uh8gBWrw3jLITfSFPawmHFDedURSLRoGottVtnMx4RbZu1u07-HLKzWvjS5HrKjxRmfErO6LcVmNXqNJy6D20e4-jbgJd-uBdDLCXECKW_ByMo4hNx610FcdAg==).\n\nCASE DETAILS: According to the Complaint, the Company made false and\nmisleading statements to the market. Hims & Hers provided customer health data\nto third-party advertising platforms. The Company’s treatment practices were\nlikely to result in heightened regulatory scrutiny. Based on these facts, the\nCompany’s public statements were false and materially misleading throughout\nthe class period. When the market learned the truth about Hims & Hers,\ninvestors suffered damages.\n\nWe also encourage you to contact Brian Schall or David Schwartz of Schall,\nBrown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA\n90067, at 310-301-3335, to discuss your rights free of charge. You can also\nreach us through the firm's website at www.schallfirm.com, or by email\nat david@schallfirm.com.\n\nThe class, in this case, has not yet been certified, and until certification\noccurs, you are not represented by an attorney. If you choose to take no\naction, you can remain an absent class member.\n\nJoin the case\n(https://www.globenewswire.com/Tracker?data=S1HeboysgfNYYyB3Wjhxa6GCAtEKjj9_tqq9Ui2nKnYzyiHF3JyNDxqZF0kmXChBD_zh1rwY6u7otweX5Y1HCCy2VYxS3E_zULi8ROt2lrlt1hEcAbw2FfXX4SNN14Y_)\nto recover your losses\n\nWHY SBS? Schall, Brown & Schwartz LLP represents investors around the world\nand specializes in securities class action lawsuits and shareholder rights\nlitigation. Bringing together the extensive experience and diverse skillsets\nof founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is\ndedicated to aggressively advocating for every investor.\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and rules of ethics.        \n\nCONTACT:\n\nSchall, Brown & Schwartz LLP\nBrian Schall, Esq.,\nAndrew Brown, Esq.,\nDavid Schwartz, Esq.,\nwww.schallfirm.com\nOffice: 310-301-3335\ninfo@schallfirm.com\n\nSOURCE:\n\n Schall, Brown & Schwartz LLP\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/0b1ae5f6-3843-4b48-9c73-0b3760ba856a)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXb8mtBm-20260929","title":"HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law ","author":"Globe Newswire","ticker":"HIMS","created":"2026-09-29T14:15:54.105Z","tickers":["HIMS"],"exchange":"NYSE","article_body":"LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) --  Schall, Brown & Schwartz LLP\n(https://www.globenewswire.com/Tracker?data=Jly_J51_tZOz2yuADjKji9KdPh-LH21Nay23erbV4Z7NlTxq3ozXiDouiwWyPZx99UC2Xs_vOtAQBszxLSP9uXJvWb86MuOaM5ov0Gl4DHyo5bAEJuVWTsphsfD9XXFr)\n(“SBS”), a national shareholder rights litigation firm, reminds investors\nof a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers”\nor “the Company”) (NYSE: HIMS\n(https://www.globenewswire.com/Tracker?data=X4FpbU2RzQy3OPeSX79TTdpwSGwqe3eLWoOlYw8AXTABu1cvkZXS3isBqubZKH0JnKAyboReRW0O0Nl17EE16h3Smm_Zb4Rb57IfrkCvLFM=))\nfor violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934\nand Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange\nCommission.\n\nShareholders who purchased shares of HIMS during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointments.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCLASS PERIOD: August 4, 2025 to July 29, 2026\n\nDEADLINE: November 2, 2026\n\nIf you are a shareholder who suffered a loss, click here to participate\n(https://www.globenewswire.com/Tracker?data=e85GHZtY26Km3i9JqGaK9yM_qzf1Uh8gBWrw3jLITfSFPawmHFDedURSLRoGottVtnMx4RbZu1u07-HLKzWvjS5HrKjxRmfErO6LcVmNXqNJy6D20e4-jbgJd-uBdDLCXECKW_ByMo4hNx610FcdAg==).\n\nCASE DETAILS: According to the Complaint, the Company made false and\nmisleading statements to the market. Hims & Hers provided customer health data\nto third-party advertising platforms. The Company’s treatment practices were\nlikely to result in heightened regulatory scrutiny. Based on these facts, the\nCompany’s public statements were false and materially misleading throughout\nthe class period. When the market learned the truth about Hims & Hers,\ninvestors suffered damages.\n\nWe also encourage you to contact Brian Schall or David Schwartz of Schall,\nBrown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA\n90067, at 310-301-3335, to discuss your rights free of charge. You can also\nreach us through the firm's website at www.schallfirm.com, or by email\nat david@schallfirm.com.\n\nThe class, in this case, has not yet been certified, and until certification\noccurs, you are not represented by an attorney. If you choose to take no\naction, you can remain an absent class member.\n\nJoin the case\n(https://www.globenewswire.com/Tracker?data=S1HeboysgfNYYyB3Wjhxa6GCAtEKjj9_tqq9Ui2nKnYzyiHF3JyNDxqZF0kmXChBD_zh1rwY6u7otweX5Y1HCCy2VYxS3E_zULi8ROt2lrlt1hEcAbw2FfXX4SNN14Y_)\nto recover your losses\n\nWHY SBS? Schall, Brown & Schwartz LLP represents investors around the world\nand specializes in securities class action lawsuits and shareholder rights\nlitigation. Bringing together the extensive experience and diverse skillsets\nof founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is\ndedicated to aggressively advocating for every investor.\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and rules of ethics.        \n\nCONTACT:\n\nSchall, Brown & Schwartz LLP\nBrian Schall, Esq.,\nAndrew Brown, Esq.,\nDavid Schwartz, Esq.,\nwww.schallfirm.com\nOffice: 310-301-3335\ninfo@schallfirm.com\n\nSOURCE:\n\n Schall, Brown & Schwartz LLP\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/0b1ae5f6-3843-4b48-9c73-0b3760ba856a)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-29T14:15:54.13897912Z","server_sent_at_ms":1790691354138},"received_at":"2026-09-29T14:15:54.190Z","source_url":null},"analysis":{"id":"144379","press_release_id":"155657","analysis_json":{"redFlags":["Alleged sharing of customer health data with third-party ad platforms may draw regulatory scrutiny"],"eventType":"legal_litigation","narrative":"Schall, Brown & Schwartz LLP issued a shareholder-solicitation notice reminding HIMS investors of a pending securities fraud class action with a November 2, 2026 lead plaintiff deadline.\n\nThe complaint alleges Hims & Hers shared customer health data with third-party advertising platforms and faced likely heightened regulatory scrutiny, making its public statements misleading during the August 4, 2025 to July 29, 2026 class period.\n\nThis is law-firm marketing, not an issuer disclosure; the class has not yet been certified and no new facts about HIMS are disclosed.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine plaintiff-firm class action solicitation -- suppress or note only the underlying privacy/regulatory allegations."},"keyFigures":{"customDimensions":{"class_period":"August 4, 2025 to July 29, 2026","lead_plaintiff_deadline":"November 2, 2026"}},"quotedText":"Hims & Hers provided customer health data to third-party advertising platforms. The Company’s treatment practices were likely to result in heightened regulatory scrutiny.","namedEntities":{"people":[{"name":"Brian Schall","role":"founding partner, Schall, Brown & Schwartz LLP"},{"name":"David Schwartz","role":"founding partner, Schall, Brown & Schwartz LLP"},{"name":"Andrew Brown","role":"founding partner, Schall, Brown & Schwartz LLP"}],"products":[],"companies":[{"name":"Schall, Brown & Schwartz LLP","relationship":"plaintiff law firm"},{"name":"Hims & Hers Health, Inc.","ticker":"HIMS","relationship":"target of class action"},{"name":"U.S. Securities and Exchange Commission","relationship":"regulator"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation by Schall, Brown & Schwartz LLP reminding investors of a class action against HIMS; no new issuer disclosure, no certified class, no settlement."},"tickerRelevance":{"others":[],"primary":"HIMS"},"globalImportance":15,"audienceRelevance":25,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"retail-favorite-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false,"underlyingAllegation":"privacy/data-sharing and regulatory risk"}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Schall, Brown & Schwartz LLP issued a shareholder-solicitation notice reminding HIMS investors of a pending securities fraud class action with a November 2, 2026 lead plaintiff deadline.\n\nThe complaint alleges Hims & Hers shared customer health data with third-party advertising platforms and faced likely heightened regulatory scrutiny, making its public statements misleading during the August 4, 2025 to July 29, 2026 class period.\n\nThis is law-firm marketing, not an issuer disclosure; the class has not yet been certified and no new facts about HIMS are disclosed.","key_figures":{"customDimensions":{"class_period":"August 4, 2025 to July 29, 2026","lead_plaintiff_deadline":"November 2, 2026"}},"named_entities":{"people":[{"name":"Brian Schall","role":"founding partner, Schall, Brown & Schwartz LLP"},{"name":"David Schwartz","role":"founding partner, Schall, Brown & Schwartz LLP"},{"name":"Andrew Brown","role":"founding partner, Schall, Brown & Schwartz LLP"}],"products":[],"companies":[{"name":"Schall, Brown & Schwartz LLP","relationship":"plaintiff law firm"},{"name":"Hims & Hers Health, Inc.","ticker":"HIMS","relationship":"target of class action"},{"name":"U.S. Securities and Exchange Commission","relationship":"regulator"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-29T14:15:59.276Z","global_importance":15,"audience_relevance":25,"importance_components":{"tickerTier":"retail-favorite-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false,"underlyingAllegation":"privacy/data-sharing and regulatory risk"}},"durationMs":5112,"modelName":"glm-5.3-flashx"}}